Advertisement
Advertisement
U.S. markets open in 3 hours 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
57.05+0.58 (+1.03%)
At close: 04:00PM EST
57.20 +0.15 (+0.26%)
After hours: 04:35PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/29/2022
Current
9/30/20226/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
7.64B5.35B6.06B5.50B5.53B5.73B
Enterprise Value
8.87B6.38B6.15B5.63B5.59B5.85B
Trailing P/E
38.1615.7514.7714.5514.4125.75
Forward P/E
N/AN/AN/A18.2523.0421.98
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
13.7911.6513.5313.2112.7914.41
Price/Book (mrq)
78.7218.2423.2827.9219.6347.89
Enterprise Value/Revenue
15.2830.5440.3648.0554.7950.54
Enterprise Value/EBITDA
30.5357.81134.6873.2396.9676.41

Trading Information

Stock Price History

Beta (5Y Monthly) 1.22
52-Week Change 377.34%
S&P500 52-Week Change 3-12.31%
52 Week High 357.67
52 Week Low 331.36
50-Day Moving Average 346.33
200-Day Moving Average 343.30

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 31.05M
Shares Outstanding 5135.21M
Implied Shares Outstanding 6N/A
Float 8133.98M
% Held by Insiders 11.08%
% Held by Institutions 1100.69%
Shares Short (Nov 14, 2022) 410.14M
Short Ratio (Nov 14, 2022) 48.25
Short % of Float (Nov 14, 2022) 48.85%
Short % of Shares Outstanding (Nov 14, 2022) 47.50%
Shares Short (prior month Oct 13, 2022) 411.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 36.37%
Operating Margin (ttm)46.51%

Management Effectiveness

Return on Assets (ttm)11.07%
Return on Equity (ttm)111.55%

Income Statement

Revenue (ttm)580.62M
Revenue Per Share (ttm)4.21
Quarterly Revenue Growth (yoy)80.40%
Gross Profit (ttm)326.23M
EBITDA 311.26M
Net Income Avi to Common (ttm)211.2M
Diluted EPS (ttm)1.53
Quarterly Earnings Growth (yoy)-71.50%

Balance Sheet

Total Cash (mrq)265.58M
Total Cash Per Share (mrq)1.96
Total Debt (mrq)1.51B
Total Debt/Equity (mrq)1,558.78
Current Ratio (mrq)5.97
Book Value Per Share (mrq)0.72

Cash Flow Statement

Operating Cash Flow (ttm)240.17M
Levered Free Cash Flow (ttm)115.47M
Advertisement
Advertisement